Blood Volume Increase:
Increases during pregnancy alongside plasma and red cell volume.
Hemoglobin (H) and hematocrit (Hct) may decline as pregnancy progresses.
Mild dilutional anemia is common as plasma volume increases, diluting red blood cells.
Anemia Considerations:
If hemoglobin (H) drops to 11 or below, iron supplementation is recommended to boost red blood cell production.
Normal anemia can occur in pregnancy, but levels below 11 require education and intervention.
Importance of Treating Anemia:
Hemoglobin is crucial for oxygen transport, benefiting both mother and fetus.
Severe anemia increases risk of complications during delivery (e.g., hemorrhage).
Women with anemia are at higher risk for requiring blood transfusions postpartum.
Testing for Gestational Diabetes:
Conducted in the second trimester via a one-hour glucose tolerance test (GTT).
Normal range for the one-hour test is less than 135 mg/dL; failures lead to a three-hour GTT.
Three-Hour GTT Parameters:
Fasting: Less than 95 mg/dL.
One Hour: Less than 180 mg/dL.
Two Hour: Less than 155 mg/dL.
Three Hour: Less than 140 mg/dL.
Diagnosis of gestational diabetes requires failing one or more of these values.
Gestational Diabetes Pathophysiology:
Insulin resistance occurs as a normal response during pregnancy.
Higher glucose levels can lead to larger-than-average (macrosomic) babies due to excess sugar intake.
Fetus produces insulin but does not receive maternal insulin; thus, post-birth hypoglycemia risk exists.
Monitoring Neonates:
Newborns of diabetic mothers require blood sugar monitoring within the first 12-24 hours postpartum.
Normal blood sugar for infants is at least 40 mg/dL at birth; normal increases to at least 45 mg/dL afterwards.
Surfactant Production:
Insulin reduces surfactant production, increasing respiratory distress risk in newborns.
Transient tachypnea of the newborn (TTN) may be common due to fluid retention.
Polyhydramnios:
Associated with gestational diabetes due to increased urine production in the fetus.
Risk of umbilical cord prolapse during delivery due to excess fluid.
Types of Hypertension:
Chronic Hypertension: Present before pregnancy or diagnosed before 20 weeks gestation.
Gestational Hypertension: Diagnosed after 20 weeks, with blood pressure ≥ 140/90 on two occasions at least 6 hours apart.
Preeclampsia:
Secretion of protein in urine (≥ 2+ on dipstick) and elevated blood pressure (≥ 140/90).
Can progress to severe preeclampsia with symptoms like headache, vision changes, and elevated liver enzymes.
Magnesium Sulfate in Preeclampsia:
Used to prevent seizures in severe cases.
Monitor for signs of magnesium toxicity (e.g., decreased respiratory rate, decreased urine output).
Calcium gluconate as an antidote for magnesium toxicity.
Non-Stress Test (NST):
Measures fetal heart rate and contractions to assess well-being.
Reactive NST requires at least two accelerations of fetal heart rate within a 20-minute monitoring:
15 beats above baseline for 15 seconds in > 32-week fetuses.
Biophysical Profile (BPP):
Combines NST with ultrasound evaluation for fetal well-being, scoring out of 10.
Assesses amniotic fluid volume, fetal movements, fetal tone, and breathing movements.
Maternal Weight Gain Recommendations:
Underweight (BMI < 18.5): Gain 28-40 pounds.
Normal weight (BMI 18.5-24.9): Gain 25-35 pounds.
Overweight (BMI 25-29.9): Gain 15-25 pounds.
Obese (BMI ≥ 30): Gain 11-20 pounds.
Dietary Recommendations:
High protein intake reduces the risk for gestational hypertension and preeclampsia.
Limit caffeine intake to below 200 mg/day.
Focus on high-fiber foods and adequate hydration to combat constipation.